{
    "type": "ETF",
    "ucits": true,
    "replication_method": "physical",
    "leverage": false,
    "inverse": false,
    "derivatives": false,
    "swaps": false,
    "complex_factors": "",
    "classification": "non-complex",
    "supporting_data": "The iShares iBonds Dec 2030 Term $ Corp UCITS ETF is a fixed income ETF that aims to track the Bloomberg MSCI December 2030 Maturity USD Corporate ESG Screened Index by investing primarily in investment grade, US Dollar denominated corporate bonds maturing in 2030. The Fund uses physical replication with sampled enhanced methodology to hold underlying bonds directly, as confirmed by the factsheet stating 'Product Structure: Physical' and 'Methodology: Sampled'. The Fund may use financial derivative instruments (FDIs) but only for limited purposes such as currency hedging (FX forwards) and possibly minor optimization; this is not an inherent part of the investment strategy but a risk management tool, so 'derivatives' is marked false. There is no mention of synthetic replication, swap agreements, total return swaps, or counterparty exposure related to swaps. The Fund is not leveraged, inverse, or amplified; no leverage ratios or terms like 'leveraged' or 'inverse' appear. The risk profile is moderate low (Risk level 3 out of 7 in PRIIPs KID, and 4 in KIID, consistent with a non-complex fixed income product). There are no capital protection or structured features such as barrier options or contingent returns. Costs are straightforward with a TER of 0.15%, no performance fees, and no complex fee structures. The Fund holds a diversified portfolio of 366 bonds with investment grade credit quality, no complex underlying assets like contingent convertible bonds or CLOs are mentioned. The ESG screening and index construction do not add complexity under MiFID II. The Fund is UCITS compliant. Overall, the absence of synthetic replication, leverage, complex derivatives, or structured features leads to a non-complex classification under MiFID II."
}